Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[C.F.C.-type ureterosigmoidostomy. Results].

J Castiñeiras Fernández1, J E Camacho González, C Sánchez-Ferragut

  • 1Servicio de Urología, Hospital Universitario Virgen Macarena.

Actas Urologicas Espanolas
|June 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results.

Cancer medicine·2025
Same author

Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Non-metastatic castration-resistant prostate cancer: management recommendations.

Actas urologicas espanolas·2022
Same author

Renal angiomyolipoma and tuberous sclerosis complex: long-term safety and efficacy outcomes of Everolimus therapy.

Actas urologicas espanolas·2021
Same author

Treatment for castration-resistant prostate cancer and drug interaction risk in polymedicated patients.

Actas urologicas espanolas·2020
Same journal

Risk factors for obturator nerve reflex during bipolar transurethral resection of lateral bladder wall tumors.

Actas urologicas espanolas·2026
Same journal

Incremental value of binary PSMA PET nodal status when added to Briganti-2019 and MSKCC models for predicting pathologic lymph node metastasis in prostate cancer.

Actas urologicas espanolas·2026
Same journal

Flexible ureteroscopy using the novel 6.3 flexible ureteroscope. Does it affect the intrarenal fluid temperature? An in vivo experimental study.

Actas urologicas espanolas·2026
Same journal

Efficacy and Safety of Mirabegron for the Treatment of Bladder Dysfunction in the Pediatric Population: A Prospective Observational Study.

Actas urologicas espanolas·2026
Same journal

Comparison of Different Encrustation Severity Scores for Residual Stone Fragments After Encrusted Double J Stent Removal.

Actas urologicas espanolas·2026
Same journal

Beyond Age: Outcomes and Predictors of Complications After Endoscopic Lithotripsy in Patients ≥ 85 years old.

Actas urologicas espanolas·2026
See all related articles

This study evaluated the C.F.C. ureterosygmoidostomy technique in 25 patients with bladder cancer or tuberculous microbladder. The technique demonstrated high rates of urinary continence with minimal complications, suggesting its efficacy in urinary diversion.

Area of Science:

  • Urology
  • Surgical Oncology
  • Nephrology

Background:

  • Bladder cancer necessitates urinary diversion, with ureterosygmoidostomy being a common technique.
  • Evaluating novel or modified techniques like the C.F.C. ureterosygmoidostomy is crucial for improving patient outcomes.

Purpose of the Study:

  • To present the results of the C.F.C. type ureterosygmoidostomy.
  • To assess the efficacy and complications of this technique in patients undergoing cystectomy for bladder neoplasia or tuberculous microbladder.

Main Methods:

  • A cohort of 25 patients (23 male, 2 female; mean age 65) with bladder cancer (24/25) or tuberculous microbladder (1/25) underwent the C.F.C. ureterosygmoidostomy.
  • Surgical procedures included radical cystoprostatectomy with bilateral lymphadenectomy for male patients and traditional cystectomy for female patients.

Related Experiment Videos

  • Follow-up was conducted over a mean period of 27 months.

    • Main Results:

    • Excellent daytime urinary continence (100%) and high nighttime continence (88%) were achieved.
    • Complications included 4 ureterointestinal strictures (resolved endoscopically) and 1 stercoral fistula (managed with colostomy).
    • Tumor progression led to death in 6/25 patients; no deaths were related to the surgical technique. No metabolic disorders were observed.

    Conclusions:

    • The C.F.C. type ureterosygmoidostomy is an effective technique for urinary diversion, offering high rates of continence.
    • The complication profile is manageable, with strictures and fistulas responsive to endoscopic or surgical intervention.
    • This technique provides a viable option for patients requiring urinary diversion following cystectomy, with favorable functional outcomes.